Eye Care (Pharmacies) - Central America

  • Central America
  • Revenue in the Eye Care market is projected to reach US$14.13m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 3.12%, resulting in a market volume of US$16.48m by 2029.
  • In global comparison, most revenue will be generated in Japan (US$904.40m in 2024).
  • In relation to total population figures, per person revenues of US$0.27 are generated in 2024.

Key regions: Canada, Europe, India, Australia, South Korea

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Eye Care (Pharmacies) market in Central America has been experiencing steady growth in recent years. Customer preferences for eye care products and services have been a key driver of this growth, along with several local special circumstances and underlying macroeconomic factors. Customer preferences in the Eye Care (Pharmacies) market in Central America have been shifting towards a greater emphasis on preventive eye care. Consumers are becoming more aware of the importance of regular eye exams and are seeking out products that can help maintain good eye health. This trend is driven by a growing aging population, increased screen time, and a general increase in awareness about eye health. As a result, there has been a rising demand for products such as contact lenses, eye drops, and vitamins specifically formulated for eye health. In addition to preventive eye care, consumers in Central America are also looking for convenience and affordability when it comes to eye care products. Many pharmacies in the region have responded to this demand by expanding their eye care offerings and providing services such as free eye exams and prescription eyewear. This has made eye care more accessible to a larger segment of the population, driving market growth. One of the key trends in the Eye Care (Pharmacies) market in Central America is the increasing popularity of online purchasing. Consumers are increasingly turning to online platforms to purchase eye care products, as it offers convenience and a wider range of options. This trend has been further accelerated by the COVID-19 pandemic, which has led to an increase in online shopping across all sectors. As a result, pharmacies in Central America have been investing in their online presence and expanding their e-commerce capabilities to cater to this growing demand. Local special circumstances also play a role in the development of the Eye Care (Pharmacies) market in Central America. The region has a high prevalence of certain eye conditions, such as cataracts and glaucoma, which require ongoing treatment and monitoring. This has created a steady demand for eye care products and services, driving market growth. Additionally, the presence of a large number of pharmacies in Central America, both independent and chain pharmacies, has contributed to the accessibility and availability of eye care products. Underlying macroeconomic factors, such as population growth, increasing disposable income, and improving healthcare infrastructure, have also contributed to the development of the Eye Care (Pharmacies) market in Central America. As the population continues to grow and incomes rise, more people are able to afford eye care products and services. Furthermore, improvements in healthcare infrastructure, such as the availability of trained eye care professionals and advanced diagnostic equipment, have made eye care more accessible and reliable. Overall, the Eye Care (Pharmacies) market in Central America is experiencing growth due to changing customer preferences, increasing online purchasing, local special circumstances, and underlying macroeconomic factors. As the market continues to develop, it is expected that there will be further expansion of product offerings, increased competition among pharmacies, and a greater emphasis on preventive eye care.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)